Mexico Shingles Vaccine Market Size & Outlook, 2023-2030

The shingles vaccine market in Mexico is expected to reach a projected revenue of US$ 11.0 million by 2030. A compound annual growth rate of 17.2% is expected of Mexico shingles vaccine market from 2024 to 2030.
Revenue, 2023 (US$M)
$3.6
Forecast, 2030 (US$M)
$11.0
CAGR, 2024 - 2030
17.3%
Report Coverage
Mexico

Mexico shingles vaccine market highlights

  • The Mexico shingles vaccine market generated a revenue of USD 3.6 million in 2023 and is expected to reach USD 11.0 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 17.2% from 2024 to 2030.
  • In terms of segment, zostavax was the largest revenue generating product in 2023.
  • Zostavax is the most lucrative product segment registering the fastest growth during the forecast period.


Shingles vaccine market data book summary

Market revenue in 2023USD 3.6 million
Market revenue in 2030USD 11.0 million
Growth rate17.2% (CAGR from 2023 to 2030)
Largest segmentZostavax
Fastest growing segmentZostavax
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationZostavax
Key market players worldwideMerck & Co Inc, Skye Bioscience Inc Ordinary Shares, Green Cross Health Ltd, Barinthus Biotherapeutics PLC ADR, CanSino Biologics Inc Class H, GSK PLC, GeneOne Life Science


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.1% of the global shingles vaccine market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil shingles vaccine market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 13.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Shingles Vaccine Market Companies

Name Profile # Employees HQ Website

Mexico shingles vaccine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to shingles vaccine market will help companies and investors design strategic landscapes.


Zostavax was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Mexico shingles vaccine market based on zostavax covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Mexico shingles vaccine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico shingles vaccine market databook

  • Our clientele includes a mix of shingles vaccine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico shingles vaccine market , including forecasts for subscribers. This country databook contains high-level insights into Mexico shingles vaccine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico shingles vaccine market size, by product, 2018-2030 (US$M)

Mexico Shingles Vaccine Market Outlook Share, 2023 & 2030 (US$M)

Mexico shingles vaccine market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more